Release and extraction of retained subfoveal perfluorocarbon liquid facilitated by subretinal BSS, vibration, and gravity: a case report.
Case report
Perfluorocarbon
Retinal detachment
Subretinal injection
Vitreoretinal surgery
Journal
BMC ophthalmology
ISSN: 1471-2415
Titre abrégé: BMC Ophthalmol
Pays: England
ID NLM: 100967802
Informations de publication
Date de publication:
23 Oct 2020
23 Oct 2020
Historique:
received:
08
08
2020
accepted:
15
10
2020
entrez:
24
10
2020
pubmed:
25
10
2020
medline:
15
5
2021
Statut:
epublish
Résumé
Perfluorocarbon liquid (PFCL) is an effective surgical adjuvant in performing vitrectomy for severe vitreoretinal pathologies such as proliferative vitreoretinopathy and giant retinal tears. However, subretinal retention of PFCL can occur postoperatively and retained PFCL causes severe visual disorders, particularly when PFCL was retained under the fovea. Although several procedures have been proposed for subfoveal PFCL removal, such as direct aspiration or submacular injection of balanced salt solution (BSS) to dislodge the subfoveal PFCL, the retinal damage associated with these procedures has been a major problem. Here, we report a case of subfoveal retention of PFCL for which we performed a novel surgical technique that attempts to minimize retinal damage. A 69-year-old man presented with subfoveal retained PFCL after surgery for retinal detachment. To remove the retained PFCL, the internal limiting membrane overlying the subretinal injection site is first peeled to allow low-pressure (8 psi) transretinal BSS infusion, using a 41-gauge cannula, to slowly detach the macula. A small drainage retinotomy is created with the diathermy tip at the inferior position of the macular bleb, sized to be slightly wider than that of the PFCL droplet. The head of the bed is then raised, and the surgeon gently vibrates the patient's head to release the PFCL droplet to allow it to migrate inferiorly towards the drainage retinotomy. The bed is returned to the horizontal position, and the PFCL, now on the retinal surface, can be aspirated. The subfoveal PFCL is removed while minimizing iatrogenic foveal and macular damage. One month after PFCL removal, the foveal structure showed partial recovery on optical coherence tomography, and BCVA improved to 20/40. Creating a macular bleb with low infusion pressure and using vibrational forces and gravity to migrate the PFCL towards a retinotomy can be considered as a relatively atraumatic technique to remove subfoveal retained PFCL.
Sections du résumé
BACKGROUND
BACKGROUND
Perfluorocarbon liquid (PFCL) is an effective surgical adjuvant in performing vitrectomy for severe vitreoretinal pathologies such as proliferative vitreoretinopathy and giant retinal tears. However, subretinal retention of PFCL can occur postoperatively and retained PFCL causes severe visual disorders, particularly when PFCL was retained under the fovea. Although several procedures have been proposed for subfoveal PFCL removal, such as direct aspiration or submacular injection of balanced salt solution (BSS) to dislodge the subfoveal PFCL, the retinal damage associated with these procedures has been a major problem. Here, we report a case of subfoveal retention of PFCL for which we performed a novel surgical technique that attempts to minimize retinal damage.
CASE PRESENTATION
METHODS
A 69-year-old man presented with subfoveal retained PFCL after surgery for retinal detachment. To remove the retained PFCL, the internal limiting membrane overlying the subretinal injection site is first peeled to allow low-pressure (8 psi) transretinal BSS infusion, using a 41-gauge cannula, to slowly detach the macula. A small drainage retinotomy is created with the diathermy tip at the inferior position of the macular bleb, sized to be slightly wider than that of the PFCL droplet. The head of the bed is then raised, and the surgeon gently vibrates the patient's head to release the PFCL droplet to allow it to migrate inferiorly towards the drainage retinotomy. The bed is returned to the horizontal position, and the PFCL, now on the retinal surface, can be aspirated. The subfoveal PFCL is removed while minimizing iatrogenic foveal and macular damage. One month after PFCL removal, the foveal structure showed partial recovery on optical coherence tomography, and BCVA improved to 20/40.
CONCLUSION
CONCLUSIONS
Creating a macular bleb with low infusion pressure and using vibrational forces and gravity to migrate the PFCL towards a retinotomy can be considered as a relatively atraumatic technique to remove subfoveal retained PFCL.
Identifiants
pubmed: 33097007
doi: 10.1186/s12886-020-01698-1
pii: 10.1186/s12886-020-01698-1
pmc: PMC7585314
doi:
Substances chimiques
Fluorocarbons
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
427Références
Br J Ophthalmol. 2008 Dec;92(12):1693-4
pubmed: 19029164
Retina. 2016 May;36(5):1035-8
pubmed: 27031529
Trans Am Acad Ophthalmol Otolaryngol. 1962 Jul-Aug;66:471-9
pubmed: 14498242
Ophthalmic Surg Lasers Imaging Retina. 2015 Oct;46(9):964-6
pubmed: 26469237
Graefes Arch Clin Exp Ophthalmol. 1993 Apr;231(4):233-7
pubmed: 8486306
Ophthalmic Surg Lasers Imaging Retina. 2013 Nov 1;44(6):577-83
pubmed: 24221464
Arch Ophthalmol. 1976 Aug;94(8):1340-6
pubmed: 949277
Arch Ophthalmol. 1989 May;107(5):761-6
pubmed: 2719587
Retina. 2004 Feb;24(1):172-6
pubmed: 15076967
Graefes Arch Clin Exp Ophthalmol. 2007 Jul;245(7):1063-4
pubmed: 17285336
Retina. 2009 Feb;29(2):248-50
pubmed: 18854788
Arch Ophthalmol. 2008 Jan;126(1):98-101
pubmed: 18195225
Am J Ophthalmol. 1988 Dec 15;106(6):668-74
pubmed: 3195646
Retina. 2006 Oct;26(8):965-8
pubmed: 17031303
PLoS One. 2018 Dec 31;13(12):e0209996
pubmed: 30596769
Ophthalmology. 2000 May;107(5):860-5
pubmed: 10811075
Retina. 2019 Oct;39 Suppl 1:S162-S168
pubmed: 28700419